The following chart describes the IFN-Alpha subtype specificity of various PBL monoclonal and polyclonal antibodies:
21100 21105 21110 21112 21125 21127 21129 31101 31110 31135 IFN-αA ++ ++ ++ ++ ++ - - ++ ++ ++ IFN-α2 ++ + ++ ++ N/A - - N/A ++ ++ IFN-αA/D ++ + + + ++ ++ + ++ ++ ++ IFN-αB2 - + - ++ N/A - - - ++ ++ IFN-αC + + + ++ N/A - ++ + ++ ++ IFN-αD ++ + ++ ++ ++ ++ ++ + ++ + IFN-αF - + - - N/A - - - ++ ++ IFN-αG ++ ++ ++ ++ N/A - ++ _ ++ ++ IFN-αH - + - ++ - - + - ++ ++ IFN-αI - + + + - - + - ++ ++ IFN-αJ + + + + - - + - ++ ++ IFN-αK + + + ++ N/A - - ++ ++ ++ IFN-α4b ++ ++ ++ + N/A - ++ N/A ++ ++ IFN-αWA - ++ - ++ N/A - - N/A ++ ++
Key:
++ Binds Well
+ Binds Moderately Well
- Does Not Bind Well
N/A Not Tested
The following chart describes the IFN-Alpha subtype specificity of various PBL monoclonal and polyclonal antibodies:
| 21100 | 21105 | 21110 | 21112 | 21125 | 21127 | 21129 | 31101 | 31110 | 31135 | |
|---|---|---|---|---|---|---|---|---|---|---|
| IFN-αA | ++ | ++ | ++ | ++ | ++ | - | - | ++ | ++ | ++ |
| IFN-α2 | ++ | + | ++ | ++ | N/A | - | - | N/A | ++ | ++ |
| IFN-αA/D | ++ | + | + | + | ++ | ++ | + | ++ | ++ | ++ |
| IFN-αB2 | - | + | - | ++ | N/A | - | - | - | ++ | ++ |
| IFN-αC | + | + | + | ++ | N/A | - | ++ | + | ++ | ++ |
| IFN-αD | ++ | + | ++ | ++ | ++ | ++ | ++ | + | ++ | + |
| IFN-αF | - | + | - | - | N/A | - | - | - | ++ | ++ |
| IFN-αG | ++ | ++ | ++ | ++ | N/A | - | ++ | _ | ++ | ++ |
| IFN-αH | - | + | - | ++ | - | - | + | - | ++ | ++ |
| IFN-αI | - | + | + | + | - | - | + | - | ++ | ++ |
| IFN-αJ | + | + | + | + | - | - | + | - | ++ | ++ |
| IFN-αK | + | + | + | ++ | N/A | - | - | ++ | ++ | ++ |
| IFN-α4b | ++ | ++ | ++ | + | N/A | - | ++ | N/A | ++ | ++ |
| IFN-αWA | - | ++ | - | ++ | N/A | - | - | N/A | ++ | ++ |
Key:
++ Binds Well
+ Binds Moderately Well
- Does Not Bind Well
N/A Not Tested
Image